1
|
Faria D, Moll-Bernardes R, Testa L, Moniz CMV, Rodrigues EC, Mota JM, Souza FR, Alves MJNN, Ono BE, Izaias JE, Sales AO, Rodrigues TS, Salemi VMC, Jordão CP, De Angelis K, Craighead DH, Rossman MJ, Bortolotto LA, Consolim-Colombo FM, Irigoyen MCC, Seals DR, Negrão CE, Sales ARK. Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors. Am J Physiol Regul Integr Comp Physiol 2023; 325:R269-R279. [PMID: 37449870 PMCID: PMC10625836 DOI: 10.1152/ajpregu.00111.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 06/27/2023] [Accepted: 07/12/2023] [Indexed: 07/18/2023]
Abstract
Previous studies show that COVID-19 survivors have elevated muscle sympathetic nerve activity (MSNA), endothelial dysfunction, and aortic stiffening. However, the neurovascular responses to mental stress and exercise are still unexplored. We hypothesized that COVID-19 survivors, compared with age- and body mass index (BMI)-matched control subjects, exhibit abnormal neurovascular responses to mental stress and physical exercise. Fifteen severe COVID-19 survivors (aged: 49 ± 2 yr, BMI: 30 ± 1 kg/m2) and 15 well-matched control subjects (aged: 46 ± 3 yr, BMI: 29 ± 1 kg/m2) were studied. MSNA (microneurography), forearm blood flow (FBF), and forearm vascular conductance (FVC, venous occlusion plethysmography), mean arterial pressure (MAP, Finometer), and heart rate (HR, ECG) were measured during a 3-min mental stress (Stroop Color-Word Test) and during a 3-min isometric handgrip exercise (30% of maximal voluntary contraction). During mental stress, MSNA (frequency and incidence) responses were higher in COVID-19 survivors than in controls (P < 0.001), and FBF and FVC responses were attenuated (P < 0.05). MAP was similar between the groups (P > 0.05). In contrast, the MSNA (frequency and incidence) and FBF and FVC responses to handgrip exercise were similar between the groups (P > 0.05). MAP was lower in COVID-19 survivors (P < 0.05). COVID-19 survivors exhibit an exaggerated MSNA and blunted vasodilatory response to mental challenge compared with healthy adults. However, the neurovascular response to handgrip exercise is preserved in COVID-19 survivors. Overall, the abnormal neurovascular control in response to mental stress suggests that COVID-19 survivors may have an increased risk to cardiovascular events during mental challenge.
Collapse
Affiliation(s)
- Diego Faria
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | | | - Laura Testa
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - Camila M V Moniz
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - Erika C Rodrigues
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
| | - Jose M Mota
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - Francis R Souza
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Maria Janieire N N Alves
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Bruna E Ono
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - João E Izaias
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - Artur O Sales
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
| | - Thais S Rodrigues
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Vera M C Salemi
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Camila P Jordão
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Katia De Angelis
- Department of Physiology, Federal University of São Paulo, São Paulo, Brazil
| | - Daniel H Craighead
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States
| | - Matthew J Rossman
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States
| | - Luiz A Bortolotto
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Fernanda M Consolim-Colombo
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Maria C C Irigoyen
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Douglas R Seals
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States
| | - Carlos E Negrão
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- Escola de Educação Física e Esporte, Universidade de São Paulo, São Paulo, Brazil
| | - Allan R K Sales
- D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- D'Or Institute for Research and Education (IDOR), São Paulo, Brazil
- Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| |
Collapse
|
2
|
Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Speck-Hernandez CA, Mota JM, Alves-Filho JC, Lima-Júnior RC, Cunha TM, Cunha FQ. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Res 2018; 78:5891-5900. [DOI: 10.1158/0008-5472.can-17-3480] [Citation(s) in RCA: 151] [Impact Index Per Article: 25.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2017] [Revised: 05/23/2018] [Accepted: 06/18/2018] [Indexed: 12/18/2022]
|
3
|
Mota JM, Brito GA, Loiola RT, Cunha FQ, Ribeiro RDA. Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis. Int Braz J Urol 2008; 33:704-10. [PMID: 17980069 DOI: 10.1590/s1677-55382007000500013] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/15/2006] [Indexed: 11/21/2022] Open
Abstract
OBJECTIVE To investigate the possible protective effect of recombinant human interleukin-11 (rhIL-11) against ifosfamide (IFS)-induced hemorrhagic cystitis (HC). MATERIALS AND METHODS Male Swiss mice (20-30g) were pretreated with rhIL-11 (25-625 mg, subcutaneously.) 30 min before intraperitoneal injection of IFS (400 mg/kg) or with saline (control group). Twelve hours later, HC was evaluated by bladder wet weight (BWW) to quantify edema, Evans blue extravasation (EBE) to measure vascular permeability, and macroscopic and microscopic analysis. All bladders were assessed by histopathological analysis. RESULTS rhIL-11 (at 125 and 625 mg) attenuated the IFS- induced increase of BWW (37.48% and 45.44%, respectively, p < 0.05) and EBE (62.35% and 56.47%, respectively, p < 0.05). IFS- induced macroscopic edema and hemorrhage and microscopic alterations, were also prevented by rhIL-11 at 625 microg. (p < 0.05). CONCLUSION Our results demonstrate a protective effect of rhIL-11 on experimental IFS- induced HC, not previously reported.
Collapse
Affiliation(s)
- Jose M Mota
- Department of Physiology, School of Medicine, Federal University of Ceara, Fortaleza, Brazil
| | | | | | | | | |
Collapse
|
7
|
Mitchell M, Sabbagha RE, Keith L, MacGregor S, Mota JM, Minoque J. Ultrasonic growth parameters in fetuses of mothers with primary addiction to cocaine. Am J Obstet Gynecol 1988; 159:1104-9. [PMID: 3055997 DOI: 10.1016/0002-9378(88)90422-x] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Sixty-seven women with primary addiction to cocaine were evaluated during their pregnancies by multiple ultrasound studies. Ultrasonic parameters included biparietal diameter, femur length, abdominal circumference, and head circumference. These values were compared with ultrasonic growth parameters in nonaddicted fetuses. Head and abdominal circumference data were used to evaluate the fetuses according to growth pattern. With this system of scoring, subtleties of asymmetric versus symmetric intrauterine growth retardation become apparent. In addition, birth weights of addicted infants were compared with birth weights of nonaddicted infants. The results suggest that, although statistically significant differences in birth weights cannot be demonstrated, abnormal growth of the addicted fetuses does occur. Addicted fetuses show a greater proportion of biparietal diameter and abdominal circumference values below the 50th and 25th percentiles than nonaddicted fetuses, and addicted fetuses more frequently exhibit intrauterine growth retardation patterns. These data suggest that it is fruitful to study these infants with near-normal size but with abnormal intrauterine growth patterns.
Collapse
Affiliation(s)
- M Mitchell
- Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, IL
| | | | | | | | | | | |
Collapse
|